Old Web
English
Sign In
Acemap
>
Paper
>
184TiPFIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered squamous NSCLC
184TiPFIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered squamous NSCLC
2019
Lucia Nogova
Florian Malchers
A Hillmer
Sabine Merkelbach-Bruse
A. Pinto
C Woempner
Richard F. Riedel
Matthias Scheffler
Sebastian Michels
P De Porre
A Santiago-Walker
R. Fischer
D. Abdulla
Roman K. Thomas
Reinhard Buettner
J. Wolf
Keywords:
Fibroblast growth factor receptor
Phases of clinical research
Pathology
Oncology
Medicine
Internal medicine
Erdafitinib
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]